AAA June 2018 – Page 19

Nimbus lights up $65m round

US-based biotechnology company Nimbus Therapeutics attracted $65m in funding yesterday from its existing shareholders, which include pharmaceutical firms Pfizer, GlaxoSmithKline, Eli Lilly and life sciences software developer Schrödinger. All but Schrödinger invested through their respective corporate venturing units, Pfizer Venture Investments, SR One and Lilly Ventures. They were joined by Atlas Venture, Lightstone Ventures and… Continue reading Nimbus lights up $65m round